CORBEIL-ESSONNES Cedex, France Clinical Trials

A listing of CORBEIL-ESSONNES Cedex, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 88 clinical trials
PHASE III RANDOMISED TRIAL TO EVALUATE FOLFOX WITH OR WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY FOR LOCALLY ADVANCED OR METASTATIC OESOPHAGO-GASTRIC CARCINOMA

Gastric cancer is the fourth commonest cancer and the second largest cause of mortality from cancer. Surgical resection of localised forms of gastric cancer offers the only chance of a cure. The vast majority of patients, however, present with advanced disease from the outset (locally advanced or metastatic) or recurrent …

Centre Hospitalier Sud Francilien
 (0.0 away) Contact site
  • 11 views
  • 26 Jan, 2021
  • +148 other locations
Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated Syndrome

The main objective of this study is to evaluate the efficacy and tolerance of 2 years of treatment with cholecalciferol (vitamin D3) in patients with a clinically isolated syndrome at high risk for MS (CIS).

CH Sud Francilien
 (0.0 away) Contact site
  • 0 views
  • 27 Jan, 2021
  • +32 other locations
Feedback in Augmented Reality to Control of Gait Parameters in Children With Cerebral Palsy

Cerebral palsy (CP) describes a group of permanent disorders of the development of movement and posture, causing activity limitation, that are attributed to non progressive disturbances that occurred in the developing fetal or infant brain. The motor disorder of CP are often accompanied by disturbances of sensation, perception, cognition, communication, …

cerebral palsy
weakness
rehabilitation therapy
prenatal
spasticity
Fondation Ellen Poidatz
 (5.6 away) Contact site
  • 0 views
  • 25 Jan, 2021
  • 1 location
Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.

This study is a prospective open label interventional multicenter study evaluating the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about follow up and prognostic evaluation of smoldering myeloma.

multiple myeloma
bone marrow plasma cells
monoclonal antibodies
monoclonal protein
amyloidosis
Centre Hospitalier Sud Francilien
 (0.0 away) Contact site
  • 0 views
  • 29 Mar, 2021
  • +37 other locations
Quality of Life in Elderly Patients With Metastatic Colorectal Cancer Receiving First-line Therapy Based on Simplified Geriatric Parameters

A national, multicenter, open-label, randomized phase III study. The trial aim is to determine the best therapeutic strategies according with the HRQoL.

adjuvant chemotherapy
metastasis
capecitabine
bevacizumab
oxaliplatin
CH Sud Ile de France
 (9.5 away) Contact site
  • 8 views
  • 03 Feb, 2021
  • +26 other locations
Robotic Rehabilitation of the Upper Limb After a Stroke

Hemiparesis is the most common motor disorder after a stroke. Most patients do not recover functional use of their paretic upper limb. The use of robotic assistance provides intensive motor training through a large number of repetitive movements, usually oriented and interactive tasks (pointing tasks, tracking paths tasks...). These feature …

hemiparesis
rehabilitation therapy
Clinique Les Trois Soleils
 (7.2 away) Contact site
  • 3 views
  • 25 Jan, 2021
  • +2 other locations
Development and Validation of a Language Screening Test in Acute Right Hemispheric Strokes

This is a bi-centric study whose main objective is the validation of a rapid screening test for language disorders in the acute phase of right hemisphere stroke. Primary objective The main objective is the validation of a rapid language disorder screening tool that will be used in the acute phase …

CH Sud Francilien
 (0.0 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +1 other locations
A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS

This is an open-label, randomized, multicenter, phase III study Patients with baseline Hb comprised between 9 and 10.5g/dl will be randomized to receive EPO Alfa 60000 UI/week for at least 12 weeks: Either at diagnosis Or at the Hb threshold chosen for RBC transfusions (must be < 9g/dl)

CHSF Gilles de Corbeil
 (0.0 away) Contact site
  • 0 views
  • 27 Jan, 2021
  • +38 other locations
Analysis of the Immune Parameters of COVID-19 Infection in Patients With Multiple Myeloma

Among all MM patients included in the cohort at the time of diagnosis of SARS-CoV-2 infection, blood samples will be collected at inclusion, at time of the infection acute phase in the most severe cases (when admitted in intensive care units), and at recovery. The following immune function tests will …

Centre Hospitalier Sud Francilien
 (1.0 away) Contact site
  • 0 views
  • 27 Mar, 2021
  • +54 other locations
Protocol Validation of Dynamometric Measurement of Passive Inter-segmental Stiffness and Spasticity in Children With Cerebral Palsy

Cerebral palsy (CP) refers to a group of movement and posture disorders responsible for activity limitation due to brain damage that occurs during fetal development or during the first year of a child's life. Given the multitude of treatment options available, the choice of treatment is a key determinant that …

Fondation Ellen Poidatz
 (5.6 away) Contact site
  • 0 views
  • 25 Feb, 2021
  • 1 location